Ledger.Open graph →
SEC Form D · Amendment · filed August 14, 2024

GelSana Therapeutics, Inc

Offering
$3.2M
Sold
$2.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
AURORA, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Jon Fernandez · Aurora, COExecDiana Verrilli · Aurora, CODirectorMike Freeman · Aurora, CODirectorJohn V. Harris · Cleveland, OHDirectorMelissa Krebs · Aurora, COExec · DirectorJon Fernandez · Aurora, COExecDan Fipke · Houston, TXDirectorMike Freeman · Aurora, CODirectorJake Bainbridge · Houston, TXExec · DirectorDiana Verrilli · Aurora, CODirectorMelissa Krebs · Aurora, COExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗